Cargando…
Gut Microbial Dysbiosis Is Associated With Profibrotic Factors in Liver Fibrosis Mice
Background and Aims: Continuous development will evolve into end-stage liver disease. Profibrotic factors NOX4 and RhoA participate in the activation of HSC and accelerate the development of liver fibrosis. Abnormal intrahepatic metabolism during liver fibrosis interferes with intestinal homeostasis...
Autores principales: | Wan, Sizhe, Nie, Yuan, Zhang, Yue, Huang, Chenkai, Zhu, Xuan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7004962/ https://www.ncbi.nlm.nih.gov/pubmed/32083022 http://dx.doi.org/10.3389/fcimb.2020.00018 |
Ejemplares similares
-
Ursolic acid improves the bacterial community mapping of the intestinal tract in liver fibrosis mice
por: Wan, Sizhe, et al.
Publicado: (2020) -
Gut microbiota dysbiosis with hepatitis B virus liver disease and association with immune response
por: Yan, Fengna, et al.
Publicado: (2023) -
Gut dysbiosis in nonalcoholic fatty liver disease: pathogenesis, diagnosis, and therapeutic implications
por: Fang, Jie, et al.
Publicado: (2022) -
Dysbiosis of the Gut Microbiome in Lung Cancer
por: Zhuang, He, et al.
Publicado: (2019) -
Dysbiosis and Implication of the Gut Microbiota in Diabetic Retinopathy
por: Huang, Yinhua, et al.
Publicado: (2021)